Codes / ICD10CM / T49.4X5

T49.4X5 Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations (ICD Code: T49.4X5)

Summary

This condition describes unintended harmful reactions resulting from the use of keratolytic, keratoplastic, or other hair treatment drugs and preparations. It includes adverse effects that occur without intentional overdose or poisoning, such as allergic reactions, irritation, or systemic responses to these substances.

Causes

Adverse effects may arise from allergic reactions to ingredients, drug interactions, or sensitivity to the formulation. Improper application, overuse, or unintended exposure (e.g., contact with eyes or mucous membranes) can also trigger reactions. Some agents may cause irritation or toxicity even when used as directed.

Risk Factors

  • History of allergic reactions to similar agents or ingredients.
  • Use of multiple hair treatment products simultaneously.
  • Impaired skin barrier (e.g., eczema, psoriasis) increasing absorption.
  • Lack of awareness of product ingredients or proper usage instructions.

Symptoms

Symptoms vary by agent and exposure route but may include skin irritation, rash, burning, itching, or systemic effects (e.g., nausea, dizziness) from absorption. Severe cases can involve anaphylaxis, respiratory distress, or organ toxicity.

Diagnosis

Diagnosis typically involves a physical examination and a review of the patient’s exposure history, including product use and timing. Clinical assessment focuses on correlating symptoms with the specific agent and route of exposure. No specific tests are required unless systemic toxicity is suspected.

Treatment Options

Treatment is supportive and symptomatic. For localized reactions, discontinuing the product and using topical corticosteroids or antihistamines may help. Systemic reactions may require monitoring, oxygen, or antihistamines. Severe cases (e.g., anaphylaxis) need immediate medical intervention, such as epinephrine.

Prognosis and Follow-Up

Prognosis is generally good with prompt treatment, especially for mild to moderate reactions. Most patients recover fully without long-term effects. Follow-up may involve monitoring for delayed reactions or ensuring proper product use to prevent recurrence.

Complications

Complications are rare but can include severe allergic reactions (e.g., anaphylaxis), skin damage (e.g., burns or scarring), or systemic toxicity if absorbed in large amounts. Chronic exposure may lead to sensitization or persistent skin issues.

Lifestyle & Prevention

  • Avoid known allergens or irritants in hair products.
  • Perform patch tests before using new products.
  • Follow product instructions carefully, especially regarding application and duration.
  • Use products in well-ventilated areas to reduce inhalation risks.

When to Seek Professional Help

Seek medical attention if symptoms worsen, spread, or include difficulty breathing, swelling, or systemic effects (e.g., dizziness, nausea). Immediate care is needed for signs of anaphylaxis (e.g., hives, throat tightness) or severe skin reactions.

Tips for Medical Coders

Document the specific agent involved, route of exposure, and clinical manifestations to support coding. Ensure the adverse effect is clearly linked to the hair treatment product and not another cause. Include details on treatment and resolution for accurate coding and reporting.

Book a walkthrough

T49.4X5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.